A new study is the first to establish a nationwide treatment protocol that can save lives of patients with cardiogenic shock (CS), a deadly heart attack complication. Findings show 72 percent of patients with CS survived ...
May 21, 2019
0
0
A deep-learning model developed using serial image scans of tumors from patients with non-small cell lung cancer (NSCLC) predicted treatment response and survival outcomes better than standard clinical parameters.
Apr 22, 2019
0
2
Acute erythroid leukemia (AEL) is a high-risk cancer with a dismal prognosis, uncertain genetic basis and controversy surrounding the diagnosis. That is changing, thanks to research led by St. Jude Children's Research Hospital ...
Mar 29, 2019
0
50
(HealthDay)—The use of robotically assisted surgical devices for breast removal and other cancer-related surgeries is not approved by the U.S. Food and Drug Administration because there is no proof of its safety or effectiveness ...
Mar 1, 2019
0
3
Fitness trackers can be valuable tools for assessing the quality of life and daily functioning of cancer patients during treatment, a new study has found. The trackers, also known as wearable activity monitors, include commercial ...
Jul 24, 2018
0
25
A DNA-level biomarker (MGMT promoter methylation) can be used to help predict survival outcomes in patients with high-risk, low-grade gliomas, according to a new study conducted through the NRG Oncology/RTOG collaborative ...
Jun 28, 2018
0
67
At this very moment, more than 110,000 people across the United States are lingering on organ transplant waiting lists. The ravages of the opioid epidemic have created an unforeseen opportunity ? an increase in the availability ...
May 16, 2018
1
1
Obese patients with metastatic melanoma live significantly longer than those with normal body mass indexes (BMI), according to a new study published in Lancet Oncology. The surprising association was mainly seen in male patients ...
Mar 26, 2018
0
2
A clinically relevant "liquid biopsy" test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer (TNBC), according to new research published ...
Feb 16, 2018
0
43
MGMT promoter methylation status—information gathered at a DNA-level—can help predict overall survival for patients with a rare form of brain cancer known as anaplastic astrocytoma, according to a new analysis from The ...
Sep 26, 2017
0
2
